Please use this identifier to cite or link to this item:
https://dora.health.qld.gov.au/qldresearchjspui/handle/1/4231| Title: | Primary intestinal lymphangiectasia in children: A review | Authors: | Lopez, R. N. Day, A. S. |
Issue Date: | 2020 | Source: | 56, (11), 2020, p. 1719-1723 | Pages: | 1719-1723 | Journal: | Journal of Paediatrics and Child Health | Abstract: | Primary intestinal lymphangiectasia is an uncommon condition that usually presents early in childhood. This incurable condition is consequent to underlying lymphatic abnormalities that lead to loss of lymphatic contents into the intestinal lumen. This article outlines an approach to the assessment of children presenting with characteristic features and consideration of other conditions that could lead to enteric protein loss. An overview of the management of primary intestinal lymphangiectasia is outlined.L20050967262020-06-03 | DOI: | 10.1111/jpc.14837 | Resources: | https://www.embase.com/search/results?subaction=viewrecord&id=L2005096726&from=exporthttp://dx.doi.org/10.1111/jpc.14837 | | Keywords: | double balloon enteroscopy;drug administration route;duodenum biopsy;feces level;histopathology;human;hypoalbuminemia;hypoplasia;immunoglobulin deficiency;intestine lymph;intestine lymphangiectasia;intestine resection;intestine surgery;lymphatic system;lymphocytopenia;priority journal;randomized controlled trial (topic);review;vitamin blood level;pathophysiology;albuminalpha 1 antitrypsin;antineoplastic agent;corticosteroid derivative;everolimus;furosemide;heparin;immunoglobulin;octreotide;plasmin inhibitor;sirolimus;vitamin D;capsule endoscopy;clinical feature;diet therapy | Type: | Article |
| Appears in Sites: | Children's Health Queensland Publications |
Show full item record
Items in DORA are protected by copyright, with all rights reserved, unless otherwise indicated.